RS51677B - Farmaceutska kompozicija koja obuhvata amlodipin bezilat i lisinopril dihidrat i postupak za njihovo dobijanje - Google Patents
Farmaceutska kompozicija koja obuhvata amlodipin bezilat i lisinopril dihidrat i postupak za njihovo dobijanjeInfo
- Publication number
- RS51677B RS51677B RS20100496A RSP20100496A RS51677B RS 51677 B RS51677 B RS 51677B RS 20100496 A RS20100496 A RS 20100496A RS P20100496 A RSP20100496 A RS P20100496A RS 51677 B RS51677 B RS 51677B
- Authority
- RS
- Serbia
- Prior art keywords
- amlodipine
- mass
- mixture
- lisinopril
- dihydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401170A HUP0401170A2 (en) | 2004-06-10 | 2004-06-10 | Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51677B true RS51677B (sr) | 2011-10-31 |
Family
ID=89985289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20100496A RS51677B (sr) | 2004-06-10 | 2005-06-09 | Farmaceutska kompozicija koja obuhvata amlodipin bezilat i lisinopril dihidrat i postupak za njihovo dobijanje |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1765342B9 (enExample) |
| AT (1) | ATE486599T1 (enExample) |
| CY (1) | CY1111484T1 (enExample) |
| DE (1) | DE602005024554D1 (enExample) |
| DK (1) | DK1765342T3 (enExample) |
| EA (1) | EA010288B1 (enExample) |
| ES (1) | ES2354618T3 (enExample) |
| HR (1) | HRP20110034T1 (enExample) |
| HU (2) | HUP0401170A2 (enExample) |
| ME (1) | ME01935B (enExample) |
| PL (1) | PL1765342T4 (enExample) |
| PT (1) | PT1765342E (enExample) |
| RS (1) | RS51677B (enExample) |
| SI (1) | SI1765342T1 (enExample) |
| WO (1) | WO2005120502A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2790817A1 (en) * | 2010-02-24 | 2011-09-01 | Sanofi-Aventis Deutschland Gmbh | Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| RU2483728C1 (ru) * | 2011-09-29 | 2013-06-10 | Общество с ограниченной ответственностью "Озон" | Комбинированное гипотензивное средство и способ его получения |
| PL227900B1 (pl) * | 2012-11-15 | 2018-01-31 | Adamed Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję |
| CN105194647A (zh) * | 2014-06-30 | 2015-12-30 | 南京瑞尔医药有限公司 | 一种含有赖诺普利和苯磺酸氨氯地平的药物组合物及其制备方法 |
| CN106333948A (zh) * | 2016-08-23 | 2017-01-18 | 成都尚药科技有限公司 | 含有苯磺酸氨氯地平和二水合赖诺普利的药物及制备方法 |
| JP7179758B2 (ja) * | 2017-04-25 | 2022-11-29 | 大塚製薬株式会社 | 摂取可能なイベントマーカを有するリシノプリル組成物 |
| GB2595203A (en) | 2020-03-03 | 2021-11-24 | Alkaloid Ad Skopje | Formulation |
| CN119730841A (zh) * | 2022-09-07 | 2025-03-28 | 拉塞·凯那司特 | Api含量提高的氨氯地平的立即释放口服药物形式 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11500140A (ja) | 1995-03-16 | 1999-01-06 | ファイザー・インコーポレーテッド | アムロジピン、アムロジピン塩、もしくはフェロジピンとace阻害薬とを含有する組成物 |
| HUP0202416A3 (en) | 2002-07-24 | 2006-01-30 | Richter Gedeon Vegyeszet | Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders |
-
2004
- 2004-06-10 HU HU0401170A patent/HUP0401170A2/hu unknown
-
2005
- 2005-06-09 AT AT05751188T patent/ATE486599T1/de active
- 2005-06-09 ME MEP-2010-496A patent/ME01935B/me unknown
- 2005-06-09 PT PT05751188T patent/PT1765342E/pt unknown
- 2005-06-09 PL PL05751188.3T patent/PL1765342T4/pl unknown
- 2005-06-09 RS RS20100496A patent/RS51677B/sr unknown
- 2005-06-09 EA EA200602187A patent/EA010288B1/ru unknown
- 2005-06-09 HU HUE05751188A patent/HUE009867T4/hu unknown
- 2005-06-09 DE DE602005024554T patent/DE602005024554D1/de not_active Expired - Lifetime
- 2005-06-09 WO PCT/HU2005/000064 patent/WO2005120502A1/en not_active Ceased
- 2005-06-09 SI SI200531194T patent/SI1765342T1/sl unknown
- 2005-06-09 HR HR20110034T patent/HRP20110034T1/hr unknown
- 2005-06-09 EP EP05751188A patent/EP1765342B9/en not_active Expired - Lifetime
- 2005-06-09 ES ES05751188T patent/ES2354618T3/es not_active Expired - Lifetime
- 2005-06-09 DK DK05751188.3T patent/DK1765342T3/da active
-
2010
- 2010-12-30 CY CY20101101203T patent/CY1111484T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005120502A1 (en) | 2005-12-22 |
| PT1765342E (pt) | 2010-12-20 |
| PL1765342T4 (pl) | 2022-11-07 |
| DE602005024554D1 (de) | 2010-12-16 |
| EA010288B1 (ru) | 2008-08-29 |
| CY1111484T1 (el) | 2015-08-05 |
| PL1765342T3 (pl) | 2011-04-29 |
| EP1765342A1 (en) | 2007-03-28 |
| ES2354618T3 (es) | 2011-03-16 |
| SI1765342T1 (sl) | 2011-02-28 |
| HUE009867T2 (enExample) | 2011-05-30 |
| EP1765342B9 (en) | 2011-02-23 |
| ME01935B (me) | 2011-10-31 |
| DK1765342T3 (da) | 2011-01-24 |
| HRP20110034T1 (hr) | 2011-02-28 |
| HUE009867T4 (hu) | 2022-01-28 |
| ATE486599T1 (de) | 2010-11-15 |
| HUP0401170A2 (en) | 2006-09-28 |
| EA200602187A1 (ru) | 2007-04-27 |
| EP1765342B1 (en) | 2010-11-03 |
| HU0401170D0 (en) | 2004-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI109453B (fi) | Farmaseuttinen koostumus | |
| US10064826B2 (en) | Direct compression and dry granulation processes for preparing carglumic acid tablets having less impurities than those produced by wet granulation process | |
| US20250152594A1 (en) | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor | |
| NZ239753A (en) | Dry granulated composition comprising water soluble salt of a basic compound and a water-soluble alkaline stabiliser | |
| CA2662265A1 (en) | Imatinib compositions | |
| CA2696977C (en) | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof | |
| EP2740471B1 (en) | Oral pharmaceutical composition comprising dabigatran etexilate | |
| CA2764172A1 (en) | A thrombin receptor antagonist and clopidogrel fixed dose tablet | |
| US20130146496A1 (en) | Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation | |
| RS51677B (sr) | Farmaceutska kompozicija koja obuhvata amlodipin bezilat i lisinopril dihidrat i postupak za njihovo dobijanje | |
| EP2179725A1 (en) | Pharmaceutical composition comprising levetiracetam | |
| EA030466B1 (ru) | Фармацевтическая композиция, обладающая улучшенной стабильностью | |
| JP6326114B2 (ja) | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 | |
| WO2015044375A1 (en) | Pharmaceutical preparation comprising dabigatran etexilate bismesylate | |
| WO2015022559A1 (en) | Pharmaceutical composition containing rosuvastatin and ramipril | |
| WO2017158094A1 (en) | Fixed dosed pharmaceutical composition comprising amiodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension. | |
| CZ2007169A3 (cs) | Farmaceutická kompozice s obsahem úcinné látky atorvastatinu | |
| CZ119498A3 (cs) | Kaptoprilové tablety | |
| EP3727344A1 (en) | Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin | |
| KR20190031660A (ko) | 안정성이 개선된 습식과립 정제 및 이의 제조방법 | |
| US20090010906A1 (en) | Peroral dosage forms to achieve a sustained-release effect after medicament dosage with a meal | |
| JP2009538905A (ja) | 感湿性薬物を含んで成る安定性製剤及びその製造方法 | |
| UA47611U (uk) | Спосіб виготовлення лікарського препарату амісульприду у твердій формі | |
| HK40070723B (zh) | 1-((2s,5r)-5-((7h-吡咯并[2,3-d]嘧啶-4-基)氨基)-2-甲基哌啶-1-基)丙-2-烯-1-酮的稳定立即释放片剂和胶囊制剂 | |
| JP2009542806A (ja) | 感湿性薬物及び第2薬物の組合せを含んで成る安定製剤及びその製造方法 |